{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:55:21Z","timestamp":1762505721284},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T00:00:00Z","timestamp":1298419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sarcoidosis is a multisystem granulomatous disease that affects multiple organs in adults between 20 and 50\u2003years old. Interferon alpha (IFN\u2010\u03b1) is an immunomodulator that has been used in a wide range of diseases, including hepatitis C virus infection, multiple sclerosis, and other types of neoplasias, including leukemia, lymphoma, Kaposi\u2019s sarcoma, and melanoma. Standard IFN\u2010\u03b1\u2010induced sarcoidosis has been reported, but there are few reports of cutaneous sarcoidosis with pegylated IFN\u2010\u03b1 therapy. We present a new case of cutaneous sarcoidosis after treatment with pegylated IFN, and a review of the literature.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2010.04728.x","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T10:25:25Z","timestamp":1298456725000},"page":"287-291","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature"],"prefix":"10.1111","volume":"50","author":[{"given":"Ver\u00f3nica","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza","family":"Jord\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,23]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80357-7"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.546"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.06.013"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.7.865"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1157\/13085136"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000157577.69729.e6"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00105.x"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80113-9"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870301)59:5<896::AID-CNCR2820590507>3.0.CO;2-4"},{"key":"e_1_2_4_11_2","first-page":"996","article-title":"A case of subcutaneous sarcoid nodules induced by interferon\u2010alpha","volume":"32","author":"Ohhata I","year":"1994","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.35.19"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.35.376"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050614"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02687.x"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-10023"},{"key":"e_1_2_4_17_2","first-page":"364","article-title":"Systemic sarcoidosis during interferon\u2010alpha therapy for chronic hepatitis C virus infection","volume":"24","author":"Cacoub P","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.1.294"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.177.1.1770199"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/120347540100500507"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-0963.2001.04570.x"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015843908536"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200208000-00013"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s535-002-8133-3"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021759120428"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200209000-00018"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0953-6205(03)00078-5"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540310016024"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1579-2129(06)60192-4"},{"key":"e_1_2_4_30_2","first-page":"CS5","article-title":"Sarcoidosis associated with interferon\u2010alpha therapy for chronic hepatitis C","volume":"10","author":"Papaioannides D","year":"2004","journal-title":"Med Sci Monit"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000134400.88832.9c"},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01575.x"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00745.x"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.1157\/13079006"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01450.x"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02099.x"},{"key":"e_1_2_4_37_2","first-page":"393","article-title":"Cutaneous sarcoidosis limited to scars following pegylated interferon alpha and ribavirin therapy in a patient with chronic hepatitis C","volume":"21","author":"Perez\u2010Gala S","year":"2007","journal-title":"JEADV"},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0209-y"},{"key":"e_1_2_4_39_2","first-page":"675","article-title":"Interferon\u2010alpha\u2010associated presumed ocular sarcoidosis","volume":"26","author":"Doycheva D","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2007.01625.x"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2010.04728.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2010.04728.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:24:50Z","timestamp":1697325890000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2010.04728.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,23]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1365-4632.2010.04728.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04728.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,23]]},"assertion":[{"value":"2011-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}